3,5-Dibromopyridine

3,5-Dibromopyridine (CAS 625-92-3) is a strategically symmetric halogenated heterocyclic scaffold engineered for cross-coupling reactions, ligand synthesis, and pharmaceutical intermediate development. Distinct from its 2,6-isomer, this molecule integrates a pyridine core with two bromine substituents at the C3 and C5 positions, creating a symmetric C₂ᵥ architecture where the bromines are meta to the ring nitrogen. This substitution pattern offers unique electronic properties compared to ortho-substituted analogs, making it particularly suitable for Pd-catalyzed cross-coupling (Suzuki, Stille, Negishi) where steric hindrance near the nitrogen needs to be minimized. The symmetric arrangement enables streamlined synthesis of C2-symmetric ligands, conjugated polymers, and bis-heterocyclic kinase inhibitors with specific binding geometries. While less activated for nucleophilic aromatic substitution (SNAr) than 2,6-dibromopyridine, the C3/C5-bromo handles provide excellent reactivity for metal-catalyzed functionalization, and the C2/C4/C6 positions remain available for electrophilic substitution or directed lithiation. Manufactured with purity ≥98% under controlled conditions, it supports drug discovery, materials science, and coordination chemistry programs requiring modular access to meta-symmetric pyridine architectures.